Ultragenyx Pharmaceutical Inc. ($RARE)
Filing Information
| Accession Number | 0001193125-26-089278 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 4, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
125,581
Total Value
$1,240,411.20
P&L
+inf% (+$1,597,923.65)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 1, 2026 | Grant/Award | 71,177 | $0.00 | $0.00 | 712,908 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 54,404 | $22.80 | $1,240,411.20 | 658,994 | Direct | โ | View Details |